Research Article
Impaired Skeletal Muscle Repair after Ischemia-Reperfusion Injury in Mice
Table 1
Cytokine expressed in the ischemic-reperfused and myotoxin-treated muscles at day 7.
| | IR+ (% uninjured) | MI+ (% uninjured) |
| Myogenesis | | | IGF-I | 71 | 63 | IGF-II | 43 | 64 | IGFBP-2 | 65 | 65 | IGFBP-3 | 107 | 122 | IGFBP-5 | 109 | 126 | IGFBP-6 | 109 | 110 | bFGF | 106 | 97 | HGF R | 0 | 19 |
| Angiogenesis | | | VEGF | 132 | 113 | VEGF R1 | 103 | 138 | VEGF R2 | 0 | 0 | VEGF R3 | 0 | 0 | VEGF-D | 0 | 0 |
| ECM remodelling | | | MMP-2 | 65 | 153 | MMP-3 | 87 | 52 | TIMP-1 | 93 | 85 | TIMP-2 | 96 | 73 | Pro-MMP-9 | 44 | 48 |
| Chemokines | | | Fractalkine | 111 | 90 | GCSF | 95 | 91 | GM-CSF | 91 | 97 | KC (IL8) | 129 | 113 | MCP1 | 75 | 85 | MCP-5 | 72 | 79 | MIP-1_ | 136 | 104 | MIP-1_ | 196 | 135 | MIP-2 | 146 | 119 | MIP-3 _ | 153 | 113 | MIP-3_ | 132 | 118 | RANTES | 119 | 141 |
| Inflammation | | | IL-1 b | 117 | 94 | IL-6 | 89 | 69 | TNF_ | 107 | 92 | sTNF RI | 146 | 94 | sTNF RII | 135 | 102 |
|
|